Medscape January 17, 2025
TOPLINE:
Wearable devices are associated with a reduced risk for major adverse cardiovascular events and all-cause mortality in patients with ischemic heart disease. However, evidence of their effects on outcomes including myocardial infarction (MI), stroke, and cardiovascular mortality remains inconclusive.
METHODOLOGY:
- Researchers conducted a systematic review and meta-analysis to study the impact of wearable devices, such as smartwatches, bands, patches, clothing, and shoes, combined with diverse technologies on cardiovascular outcomes in adult patients with ischemic heart disease.
- Six randomized clinical trials that included patients with ischemic heart disease (mean/median age, 43.2-75.6 years; 73%-82% men) were included in the final analysis, with meta-analyses performed when possible.
- Patients used wearable devices alongside either usual care alone or usual care plus additional...
Today's Sponsors
Today's Sponsor